Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Assays designed to monitor patients being treated with platelet inhibitors to prevent thrombosis, alter the course of atherosclerosis, or prolong vascular graft patency.
The Cube CYP2C19 External Control Cartridges are cartridges that contain required material to run an external control test on the Genomadix Cube system. Quantity: 10 Control Tests.
The Cube CYP2C19 Swab Kit is a pouch containing 3 swabs, used to collect buccal samples from the inside of a patient’s cheek. Quantity: 20 pouches (3 swabs/pouch)
MW 419.89 g/mol, Purity >99%. Potent, selective P2Y₁₂ antagonist. Potent antithrombotic drug that inhibits ADP-induced platelet aggregation. Clopidogrel is not active in vitro and is the precursor to an active metabolite formed in the liver.
MW 419.89 g/mol, Purity >99%. Potent, selective P2Y₁₂ antagonist. Potent antithrombotic drug that inhibits ADP-induced platelet aggregation. Clopidogrel is not active in vitro and is the precursor to an active metabolite formed in the liver.